WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2020

Apr 30, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2020-04-28

Reporting Person: Abraham Silji (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-28	Common Stock	M	500.00	$86.24	Acquired	5041.00	Direct
2020-04-28	Common Stock	S	500.00	$200.6562	Disposed	4541.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-28	Stock Options (Right to buy)	$86.24	M	500.00	Disposed	2028-02-26	Common Stock (500.00)	Direct

Footnotes

F1: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $200.445 to $201.0509, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.